787 related articles for article (PubMed ID: 1655229)
1. Reappraisal of internal mammary node metastases as a prognostic factor in patients with breast cancer.
Noguchi M; Ohta N; Koyasaki N; Taniya T; Miyazaki I; Mizukami Y
Cancer; 1991 Nov; 68(9):1918-25. PubMed ID: 1655229
[TBL] [Abstract][Full Text] [Related]
2. [Prognostic significance of internal mammary lymph node metastases in breast cancer patients].
Noguchi M; Ota N; Koyazaki N; Taniya T; Miyazaki I; Mizukami Y
Nihon Geka Gakkai Zasshi; 1992 Mar; 93(3):295-9. PubMed ID: 1513310
[TBL] [Abstract][Full Text] [Related]
3. Lymph node metastases versus DNA ploidy as prognostic factors for invasive ductal carcinoma of the breast.
Noguchi M; Taniya T; Ohta N; Koyasaki N; Miyazaki I; Mizukami Y
Breast Cancer Res Treat; 1991 Sep; 19(1):23-31. PubMed ID: 1661623
[TBL] [Abstract][Full Text] [Related]
4. Prognosis of breast cancer patients after mastectomy and dissection of internal mammary nodes.
Veronesi U; Cascinelli N; Greco M; Bufalino R; Morabito A; Galluzzo D; Conti R; De Lellis R; Delle Donne V; Piotti P
Ann Surg; 1985 Dec; 202(6):702-7. PubMed ID: 3000303
[TBL] [Abstract][Full Text] [Related]
5. Internal mammary nodal status is a more reliable prognostic factor than DNA ploidy and c-erb B-2 expression in patients with breast cancer.
Noguchi M; Koyasaki N; Ohta N; Kitagawa H; Earashi M; Thomas M; Miyazaki I; Mizukami Y
Arch Surg; 1993 Feb; 128(2):242-6. PubMed ID: 8094282
[TBL] [Abstract][Full Text] [Related]
6. The relationship between lymph node metastases and DNA-ploidy status as prognostic factors in invasive breast cancer.
Noguchi M; Ohta N; Koyasaki N; Taniya T; Miyazaki I; Mizukami Y
Surg Today; 1992; 22(3):213-20. PubMed ID: 1392324
[TBL] [Abstract][Full Text] [Related]
7. Risk of internal mammary lymph node metastases and its prognostic value in breast cancer patients.
Noguchi M; Ohta N; Thomas M; Kitagawa H; Miyazaki I
J Surg Oncol; 1993 Jan; 52(1):26-30. PubMed ID: 8441257
[TBL] [Abstract][Full Text] [Related]
8. Can we identify the group of small invasive (T1a,b) breast cancers with minimal risk of axillary lymph node involvement? A pathohistological and DNA flow cytometric study.
Bezić J; Samija-Projić I; Projić P; Ljubković J; Capkun V; Tomić S
Pathol Res Pract; 2011 Jul; 207(7):438-42. PubMed ID: 21689895
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions.
White RE; Vezeridis MP; Konstadoulakis M; Cole BF; Wanebo HJ; Bland KI
J Am Coll Surg; 1996 Dec; 183(6):575-82. PubMed ID: 8957459
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of internal mammary node dissection in the treatment of breast cancer.
Horino T; Fujita M; Ueda N; Ota J; Ryo M; Nakano Y; Taguchi T
Jpn J Clin Oncol; 1991 Dec; 21(6):422-7. PubMed ID: 1805047
[TBL] [Abstract][Full Text] [Related]
11. Lymphatic mapping and sentinel lymphadenectomy in early stage breast carcinoma.
Altinyollar H; Kapucuoglu N; Pak I; Berberoglu U
J Exp Clin Cancer Res; 2000 Jun; 19(2):141-4. PubMed ID: 10965808
[TBL] [Abstract][Full Text] [Related]
12. Predictors of axillary lymph node metastases in patients with T1 breast carcinoma.
Barth A; Craig PH; Silverstein MJ
Cancer; 1997 May; 79(10):1918-22. PubMed ID: 9149018
[TBL] [Abstract][Full Text] [Related]
13. Axillary lymph node dissection in pT1 breast cancer: a retrospective analysis of 315 patients and review of the literature.
Witt A; Obwegeser R; Auerbach L; Tempfer C; Yavuz D; Kubista E
Wien Klin Wochenschr; 2002 Jun; 114(10-11):387-90. PubMed ID: 12708092
[TBL] [Abstract][Full Text] [Related]
14. C-erbB-2 oncoprotein expression versus internal mammary lymph node metastases as additional prognostic factors in patients with axillary lymph node-positive breast cancer.
Noguchi M; Koyasaki N; Ohta N; Kitagawa H; Earashi M; Thomas M; Miyazaki I; Mizukami Y
Cancer; 1992 Jun; 69(12):2953-60. PubMed ID: 1350504
[TBL] [Abstract][Full Text] [Related]
15. Sentinel lymph node biopsy in patients with previous ipsilateral complete axillary lymph node dissection.
Kaur P; Kiluk JV; Meade T; Ramos D; Koeppel W; Jara J; King J; Cox CE
Ann Surg Oncol; 2011 Mar; 18(3):727-32. PubMed ID: 20593244
[TBL] [Abstract][Full Text] [Related]
16. Complete axillary lymph node dissection for stage I-II carcinoma of the breast.
Danforth DN; Findlay PA; McDonald HD; Lippman ME; Reichert CM; d'Angelo T; Gorrell CR; Gerber NL; Lichter AS; Rosenberg SA
J Clin Oncol; 1986 May; 4(5):655-62. PubMed ID: 3701387
[TBL] [Abstract][Full Text] [Related]
17. A multivariate study of the relationship between regional lymph node metastases and prognosis in patients with operable breast cancer.
Noguchi M; Taniya T; Koyasaki N; Ohta N; Miyazaki I
Jpn J Surg; 1991 Nov; 21(6):613-20. PubMed ID: 1664901
[TBL] [Abstract][Full Text] [Related]
18. Risk of internal mammary lymph node metastases and its relevance on prognosis of breast cancer patients.
Veronesi U; Cascinelli N; Bufalino R; Morabito A; Greco M; Galluzzo D; Delle Donne V; De Lellis R; Piotti P; Sacchini V
Ann Surg; 1983 Dec; 198(6):681-4. PubMed ID: 6639172
[TBL] [Abstract][Full Text] [Related]
19. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
[TBL] [Abstract][Full Text] [Related]
20. The value of radiotherapy on metastatic internal mammary nodes in breast cancer. Results on a large series.
Veronesi U; Arnone P; Veronesi P; Galimberti V; Luini A; Rotmensz N; Botteri E; Ivaldi GB; Leonardi MC; Viale G; Sagona A; Paganelli G; Panzeri R; Orecchia R
Ann Oncol; 2008 Sep; 19(9):1553-60. PubMed ID: 18467318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
